New York bills · 2025 Regular Session
New York A 3833
Relates to capping cost sharing for antiviral COVID-19 therapeutics
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- David Weprin (Democratic)
Summary
Official abstract published by the New York legislature
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · House
REFERRED TO INSURANCE - Jan 30, 2025 · House
REFERRED TO INSURANCE